Cancer virotherapy is conducted according to individual injection protocols and in accordance with the “Rigvir Guidelines on the Use in Oncology” under the supervision of healthcare professionals. The average treatment period is 3 years, during which a regular monitoring of tests and the patient's overall state of health takes place.
Cancer virotherapy is a treatment method that is gentle to the body and has minimum side effects. Most common side effect is slightly increased body temperature (up to 37.5°C, 99.5°F) lasting one to three days.
To learn more about virotherapy visit For Patients section or International Virotherapy Center: www.virotherapy.com/treatment/
Cancer virotherapy can be practiced by healthcare professionals who have completed the educational course to apply this treatment and prescribe virotherapy medication.
If you wish to find out more about possibilities of virotherapy treatment, please visit For Patients section and find out if virotherapy can help you by filling the form or contact the patient information center of International Virotherapy Center by e-mail: info@virotherapy.com.
Training for healthcare professionals is organised by International Virotherapy Center in cooperation with the International Virotherapy Association.
If you wish to complete the training course and receive a certificate, please contact International Virotherapy Center by e-mail: info@virotherapy.com.
Rigvir should be stored at -20°C (-4°F) and transported frozen.
International partner in transport organisation: www.medserviceagency.eu